| Business Name: |
Lospinuso Michael F MD |
| Contact Person: |
Michael Lospinuso, |
| Address: |
2315 Highway 34 # D, Manasquan, New Jersey 08736 |
| Phone Number: |
(732) 974-0404 |
| Annual Revenue (USD): |
$500.000 to $999.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
6211110 |
| Share This Business: |
|
| Related Businesses: |
Weisberg Steven MD - Manasquan, NJ 08736
Patel Hiren R MD - Manasquan, NJ 08736
Graule Melissa J MD - Manasquan, NJ 08736
Levitt Michael J MD - Manasquan, NJ 08736
Begleiter David A MD - Manasquan, NJ 08736
Gualtieri Louis B DO - Manasquan, NJ 08736
Brezel Mitchell H MD - Manasquan, NJ 08736
Simpson Alan J MD - Manasquan, NJ 08736
Lepis Michael A MD - Manasquan, NJ 08736
Greenberg David B MD - Manasquan, NJ 08736
Mencel Peter J MD - Manasquan, NJ 08736
Viswambharan Ajay MD - Manasquan, NJ 08736
Shah Amar MD - Manasquan, NJ 08736
Modem Pain Therapy - Manasquan, NJ 08736
Welt Alan MD - Manasquan, NJ 08736
Saez-Lacy Deborah MD - Manasquan, NJ 08736
Leitner Robyn MD - Manasquan, NJ 08736
Pancurak James MD - Manasquan, NJ 08736
DE LA Luz Gustavo E MD - Manasquan, NJ 08736
Lerner William MD - Manasquan, NJ 08736
|
The company Lospinuso Michael F MD provides B2C services in the form of Doctors from its single location in New Jersey.
1 to 4 employees work for Lospinuso Michael F MD, and the business now earns $500.000 to $999.999 per annum.
Lospinuso Michael F MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 .
To contact Lospinuso Michael F MD, please call Michael Lospinuso, with the phone number (732) 974-0404 or visit its single location at 2315 Highway 34 # D in Manasquan, New Jersey 08736.
The location of the single location can also be found using the coordinates 40.13683,-74.09068.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.